u/britt_marchand

Agreed on assay changes. A lab switching platforms between your draws is invisible unless you ask.

How many weeks between the two measurements?

Added ApoB to the panel after a thread here. It told me something the standard lipid panel had been hiding.

Did anything else change in that window — training, intake, hydration?

lab reference ranges are not treatment targets

The confounding problem, stated plainly, because this board keeps stepping on it.

edit_for_clarity is right that a reference interval is not a target. It is a description of a population.

Careful — that is a question for whoever ordered the panel, and nobody in this thread can answer it responsibly.

ApoB is the one worth adding if you only add one

Substantial weight loss independently moves lipids, liver enzymes and several other markers. Attributing a change to a compound while losing weight is confounded by design.

assay method matters, especially between different labs

Right, and weight loss itself moves several markers, so attribution is harder than these threads assume.

Push back: a value just outside a reference interval is a common finding in healthy people. It is a reason to repeat.

Brought the whole set to my clinician rather than one flagged value. Completely different conversation.

weight loss itself moves several of these independently

Is that the same assay, or did the lab change platforms?

do not change three things and then read the panel

Different laboratories use different assay platforms with different calibration.

Agreed — and standardising the draw conditions is the cheapest improvement available.

ask whether the lab changed its assay between your two draws